IRCT20191221045837N3RecruitingPhase 2
Evaluation of the Effectiveness of Nanomicelle Curcumin Formulation on Clinical and Spirometry Parameters of Asthma in Children
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Recruiting
- Enrollment
- 90
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 6 years to 12 years (—)
- Sex
- All
Inclusion Criteria
- •Pediatric patients admitted to allergy subspecialized clinic of Akbar hospital
- •6-12 years old
- •With mild persistant asthma based on Global Initiative for Asthma (GINA) 2019 guideline
- •Informed consent of patient/caregiver
Exclusion Criteria
- •Patients with pulmunary infection
- •Patients with underlying cardiac, hepatic, biliary, renal, or gastrointestinal diseases or allergic rhinitis
- •Patients with smoker parents
- •Patients taking anticoagolant or antiplatelet medications
- •Patients with diabetes
Investigators
Similar Trials
Recruiting
Phase 2
Effect of Nanomicelle Curcumin in Ulcerative ColitisUlcerative colitisIRCT20191221045837N2Mashhad University of Medical Sciences40
Not yet recruiting
Phase 2
Effect of Nano-Curcumin in Juvenile Idiopathic ArthritisChildren with Juvenile Idiopathic Arthritis(JIA).Juvenile arthritisIRCT20191221045837N1Mashhad University of Medical Sciences40
Recruiting
Phase 3
effects of curcumine in strokeAcute ischemic stroke.Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteriesIRCT20180803040679N1Mashhad University of Medical Sciences80
Completed
Phase 1
Therapeutic effect of curcumin on ulcerative culitiesulcerative colitis.IRCT2017071435080N1EXIR nano sina40
Recruiting
Phase 3
The effect of nanomicelle curcumin in children with Crohn's diseaseChildren's Crohn's disease.Crohn's disease [regional enteritis]IRCT20231029059889N1Mashhad University of Medical Sciences60